NCT04666688 2025-02-12LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsPureTechPhase 1/2 Completed44 enrolled
NCT03684811 2023-11-18A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationNovo Nordisk A/SPhase 1/2 Completed93 enrolled 24 charts
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT02128282 2021-10-22Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of CholangiocarcinomaSenhwa Biosciences, Inc.Phase 1/2 Completed127 enrolled
NCT00634751 2019-11-26CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaUniversity of Wisconsin, MadisonPhase 1/2 Completed48 enrolled 13 charts
NCT00004910 2012-06-06Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionNorthwestern UniversityPhase 1/2 Completed
NCT00021047 2012-03-08Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed